{"cik":320017,"taxonomy":"us-gaap","tag":"ShareBasedCompensation","label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","entityName":"LISATA THERAPEUTICS, INC.","units":{"USD":[{"start":"2023-01-01","end":"2023-12-31","val":2038000,"accn":"0000320017-25-000011","fy":2024,"fp":"FY","form":"10-K","filed":"2025-02-27","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":1653000,"accn":"0000320017-25-000011","fy":2024,"fp":"FY","form":"10-K","filed":"2025-02-27"},{"start":"2024-01-01","end":"2024-12-31","val":1653000,"accn":"0000320017-26-000023","fy":2024,"fp":"FY","form":"10-K","filed":"2026-03-12","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":530000,"accn":"0000320017-26-000032","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-11","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-12-31","val":1226000,"accn":"0000320017-26-000023","fy":2024,"fp":"FY","form":"10-K","filed":"2026-03-12","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":364000,"accn":"0000320017-26-000032","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-11","frame":"CY2026Q1"}]}}